10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
PharmacotherapeuticspforpAdvancedpPracticepNursepPrescribersp5thpEditionpWoopRobinsonpTestpBank
Chapterp1.pThepRolepofpthepNursepPractitio
nerpMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
about:blank 1/248
,10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
PharmacotherapeuticspforpAdvancedpPracticepNursepPrescribersp5thpEditionpWoopRobinsonpTestpBank
Chapterp1.pThepRolepofpthepNursepPractitio
nerpMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
1. Nursep practitionerp prescriptivep authorityp isp regulatedp by:
1. Thep Nationalp Councilp ofp Statep Boardsp ofp Nursing
2. Thep U.S.p Drugp Enforcementp Administration
3. ThepStatep Boardp ofpNursingp forp eachpstate
4. Thep Statep Boardp ofp Pharmacy
2. Thep benefitsp top thep patientp ofp havingp anp Advancedp Practicep Registeredp Nursep (APRN)p prescr
iberpinclude:
1. Nursesp knowp morep aboutp Pharmacologyp thanp otherp prescribersp becausep theyp tak
ep itpbothpinptheirpbasicpnursingpprogrampandpinptheirpAPRNpprogram.
2. Nursesp carep forp thep patientp fromp ap holisticp approachp andp includep thep patien
tp inpdecisionpmakingpregardingptheirpcare.
3. APRNsp arep lessp likelyp top prescribep narcoticsp andp otherp controlledp substances.
4. APRNsp arep ablep top prescribep independentlyp inp allp states,p whereasp ap physician’s
assistantp needsp top havep ap physicianp supervisingp theirp practice.
3. Clinicalp judgmentp inp prescribingp includes:
1. Factoringp inp thep costp top thep patientp ofp thep medicationp prescribed
2. Alwaysp prescribingp thep newestp medicationp availablep forp thep diseasep process
3. Handingp outp drugp samplesp top poorp patients
4. Prescribingp allp genericp medicationsp top cutp costs
4. Criteriap forp choosingp anp effectivep drugp forp ap disorderp include:
1. Askingpthep patientp whatp drugp theyp thinkp wouldp workp bestp forp them
2. Consultingp nationallyp recognizedp guidelinesp forp diseasep management
3. Prescribingp medicationsp thatp arep availablep asp samplesp beforep writingp ap prescription
4. Followingp U.S.p Drugp Enforcementp Administrationp guidelinesp forp prescribing
5. Nursep practitionerp practicep mayp thrivep underp health-carep reformp becausep of:
1. Thep demonstratedp abilityp ofp nursep practitionersp top controlp costsp andp improvep pati
entpoutcomes
2. Thep factp thatp nursep practitionersp willp bep ablep top practicep independently
3. Thep factp thatp nursep practitionersp willp havep fullp reimbursementp underp health-
carepreform
4. Thep abilityp top shiftp accountabilityp forp Medicaidp top thep statep level
about:blank 2/248
,10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
Chapterp1.pThepRolepofpthepNursepPractitio
nerpAnswerpSection
MULTIPLEpCHOICE
1.pANS: 3 PTS: 1
2.pANS: 2 PTS: 1
3.pANS: 1 PTS: 1
about:blank 3/248
, 10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
Chapterp1.pThepRolepofpthepNursepPractitio
nerpAnswerpSection
MULTIPLEpCHOICE
1.pANS: 3 PTS: 1
2.pANS: 2 PTS: 1
3.pANS: 1 PTS: 1
4.pANS: 2 PTS: 1
5.pANS: 1 PTS: 1
Chapterp2.pReviewpofpBasicpPrinciplespofpPharmacol
ogypMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
1. Ap patient’sp nutritionalp intakep andp laboratoryp resultsp reflectp hypoalbuminemia.p Thisp isp criticalp to
prescribingp because:
1. Distributionp ofp drugsp top targetp tissuep mayp bep affected.
2. Thepsolubilityp ofp thep drugpwillp notp matchp thep sitep ofp absorption.
3. Therepwillp bep lessp freep drugp availablep top generatep anp effect.
4. Drugsp boundp top albuminp arep readilyp excretedp byp thep kidneys.
2. Drugsp thatp havep ap significantp first-passp effect:
1. Mustpbep givenpbyp thep enteralp(oral)p routep only
2. Bypassp thep hepaticp circulation
3. Arep rapidlyp metabolizedp byp thep liverp andp mayp havep littlep ifp anyp desiredp action
4. Arep convertedp byp thep liverp top morep activep andp fat-solublep forms
3. Theproutepofp excretionpofp ap volatilep drugp willp likelyp bep the:
1. Kidneys
2. Lungs
3. Bilepandp feces
4. Skin
4. Medroxyprogesteronep (Depop Provera)p isp prescribedp intramuscularlyp (IM)p top createp ap stora
gepreservoirpofpthepdrug.pStoragepreservoirs:
1. Assurep thatp thep drugp willp reachp itsp intendedp targetp tissue
2. Arep thep reasonp forp givingp loadingp doses
3. Increasepthep lengthp ofptimep ap drugp isp availablep andpactive
4. Arep mostp commonp inp collagenp tissues
5. Thep NPp choosesp top givep cephalexinp everyp 8p hoursp basedp onp knowledgep ofp thep drug’s:
1. Propensityptop gop top thep targetp receptor
2. Biologicalp half-life
3. Pharmacodynamics
4. Safetypandp sidep effects
6. Azithromycinpdosingp requiresp thatp thep firstp day’sp dosagepbep twicep thosep ofp thep otherp 4p dayspofp the
prescription.p Thisp isp consideredp ap loadingp dose.p Ap loadingp dose:
1. Rapidlyp achievesp drugp levelsp inp thep therapeuticp range
2. Requiresp four-p top five-half-livesp top attain
3. Isp influencedp byp renalp function
4. Ispdirectlyp relatedp top thep drugp circulatingp top thep targetp tissues
7. Thep pointp inp timep onp thep drugp concentrationp curvep thatp indicatesp thep firstp signp ofp ap therapeuticp e
ffectpispthe:
about:blank 4/248
…
PharmacotherapeuticspforpAdvancedpPracticepNursepPrescribersp5thpEditionpWoopRobinsonpTestpBank
Chapterp1.pThepRolepofpthepNursepPractitio
nerpMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
about:blank 1/248
,10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
PharmacotherapeuticspforpAdvancedpPracticepNursepPrescribersp5thpEditionpWoopRobinsonpTestpBank
Chapterp1.pThepRolepofpthepNursepPractitio
nerpMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
1. Nursep practitionerp prescriptivep authorityp isp regulatedp by:
1. Thep Nationalp Councilp ofp Statep Boardsp ofp Nursing
2. Thep U.S.p Drugp Enforcementp Administration
3. ThepStatep Boardp ofpNursingp forp eachpstate
4. Thep Statep Boardp ofp Pharmacy
2. Thep benefitsp top thep patientp ofp havingp anp Advancedp Practicep Registeredp Nursep (APRN)p prescr
iberpinclude:
1. Nursesp knowp morep aboutp Pharmacologyp thanp otherp prescribersp becausep theyp tak
ep itpbothpinptheirpbasicpnursingpprogrampandpinptheirpAPRNpprogram.
2. Nursesp carep forp thep patientp fromp ap holisticp approachp andp includep thep patien
tp inpdecisionpmakingpregardingptheirpcare.
3. APRNsp arep lessp likelyp top prescribep narcoticsp andp otherp controlledp substances.
4. APRNsp arep ablep top prescribep independentlyp inp allp states,p whereasp ap physician’s
assistantp needsp top havep ap physicianp supervisingp theirp practice.
3. Clinicalp judgmentp inp prescribingp includes:
1. Factoringp inp thep costp top thep patientp ofp thep medicationp prescribed
2. Alwaysp prescribingp thep newestp medicationp availablep forp thep diseasep process
3. Handingp outp drugp samplesp top poorp patients
4. Prescribingp allp genericp medicationsp top cutp costs
4. Criteriap forp choosingp anp effectivep drugp forp ap disorderp include:
1. Askingpthep patientp whatp drugp theyp thinkp wouldp workp bestp forp them
2. Consultingp nationallyp recognizedp guidelinesp forp diseasep management
3. Prescribingp medicationsp thatp arep availablep asp samplesp beforep writingp ap prescription
4. Followingp U.S.p Drugp Enforcementp Administrationp guidelinesp forp prescribing
5. Nursep practitionerp practicep mayp thrivep underp health-carep reformp becausep of:
1. Thep demonstratedp abilityp ofp nursep practitionersp top controlp costsp andp improvep pati
entpoutcomes
2. Thep factp thatp nursep practitionersp willp bep ablep top practicep independently
3. Thep factp thatp nursep practitionersp willp havep fullp reimbursementp underp health-
carepreform
4. Thep abilityp top shiftp accountabilityp forp Medicaidp top thep statep level
about:blank 2/248
,10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
Chapterp1.pThepRolepofpthepNursepPractitio
nerpAnswerpSection
MULTIPLEpCHOICE
1.pANS: 3 PTS: 1
2.pANS: 2 PTS: 1
3.pANS: 1 PTS: 1
about:blank 3/248
, 10/9/23,p1:46pAM TESTpBANKpPharmacotherapeuticspFORpAdvancedpPracticepNursepPrescri
…
Chapterp1.pThepRolepofpthepNursepPractitio
nerpAnswerpSection
MULTIPLEpCHOICE
1.pANS: 3 PTS: 1
2.pANS: 2 PTS: 1
3.pANS: 1 PTS: 1
4.pANS: 2 PTS: 1
5.pANS: 1 PTS: 1
Chapterp2.pReviewpofpBasicpPrinciplespofpPharmacol
ogypMultiplepChoice
Identifyp thep choicep thatp bestp completesp thep statementp orp answersp thep question.
1. Ap patient’sp nutritionalp intakep andp laboratoryp resultsp reflectp hypoalbuminemia.p Thisp isp criticalp to
prescribingp because:
1. Distributionp ofp drugsp top targetp tissuep mayp bep affected.
2. Thepsolubilityp ofp thep drugpwillp notp matchp thep sitep ofp absorption.
3. Therepwillp bep lessp freep drugp availablep top generatep anp effect.
4. Drugsp boundp top albuminp arep readilyp excretedp byp thep kidneys.
2. Drugsp thatp havep ap significantp first-passp effect:
1. Mustpbep givenpbyp thep enteralp(oral)p routep only
2. Bypassp thep hepaticp circulation
3. Arep rapidlyp metabolizedp byp thep liverp andp mayp havep littlep ifp anyp desiredp action
4. Arep convertedp byp thep liverp top morep activep andp fat-solublep forms
3. Theproutepofp excretionpofp ap volatilep drugp willp likelyp bep the:
1. Kidneys
2. Lungs
3. Bilepandp feces
4. Skin
4. Medroxyprogesteronep (Depop Provera)p isp prescribedp intramuscularlyp (IM)p top createp ap stora
gepreservoirpofpthepdrug.pStoragepreservoirs:
1. Assurep thatp thep drugp willp reachp itsp intendedp targetp tissue
2. Arep thep reasonp forp givingp loadingp doses
3. Increasepthep lengthp ofptimep ap drugp isp availablep andpactive
4. Arep mostp commonp inp collagenp tissues
5. Thep NPp choosesp top givep cephalexinp everyp 8p hoursp basedp onp knowledgep ofp thep drug’s:
1. Propensityptop gop top thep targetp receptor
2. Biologicalp half-life
3. Pharmacodynamics
4. Safetypandp sidep effects
6. Azithromycinpdosingp requiresp thatp thep firstp day’sp dosagepbep twicep thosep ofp thep otherp 4p dayspofp the
prescription.p Thisp isp consideredp ap loadingp dose.p Ap loadingp dose:
1. Rapidlyp achievesp drugp levelsp inp thep therapeuticp range
2. Requiresp four-p top five-half-livesp top attain
3. Isp influencedp byp renalp function
4. Ispdirectlyp relatedp top thep drugp circulatingp top thep targetp tissues
7. Thep pointp inp timep onp thep drugp concentrationp curvep thatp indicatesp thep firstp signp ofp ap therapeuticp e
ffectpispthe:
about:blank 4/248
